Ajanta Pharma Limited
AJANTPHARM
Rang in aandelen
#3695
Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited... Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited operates as a specialized pharmaceutical enterprise. This company, along with its subsidiaries, is dedicated to the development, manufacturing, and commercialization of finished dosage forms. Its extensive product range caters to numerous therapeutic categories, such as anti-infectives (antibiotic, anti-malarial), chronic disease management (anti-diabetic, cardiology), women's health (gynecology), pediatrics, respiratory ailments, general health, dermatology, ophthalmology, and pain management. Notable products include multivitamins, antibiotics, eye drops, and cough syrups. Ajanta Pharma boasts a substantial international footprint, operating across India, Africa, other parts of Asia, the United States, and additional global markets. Furthermore, it supplies its pharmaceutical offerings to various government entities, including armed forces, public hospitals, and governmental procurement departments.
Aandeelprijs
$36.41
Laatst gesynchroniseerd: 2026-10-19
Marktkapitalisatie
$4.55B
Verandering (1 dag)
-0.54%
Verandering (1 jaar)
31.32%
Land
IN
Handel Ajanta Pharma Limited (AJANTPHARM)
Categorie
Healthcare
EPS voor Ajanta Pharma Limited (AJANTPHARM)
EPS per June 2026 TTM: $1.00
Volgens de laatste financiële rapporten en de aandelenkoers van Ajanta Pharma Limited is de huidige EPS van het bedrijf (TTM) $1.00. Eind 2024 had het bedrijf een EPS van $0.78, een stijging ten opzichte van de EPS van 2023 die $0.56 bedroeg.
EPS-geschiedenis van Ajanta Pharma Limited van 2005 tot 2026
EPS aan het einde van elk jaar
| Jaar | EPS | Wijzigen |
|---|---|---|
| 2026 (TTM) | $1.00 | 16.57% |
| 2025 | $0.86 | 10.64% |
| 2024 | $0.78 | 39.22% |
| 2023 | $0.56 | -22.89% |
| 2022 | $0.72 | 5.91% |
| 2021 | $0.68 | 44.17% |
| 2020 | $0.47 | 12.34% |
| 2019 | $0.42 | -22.56% |
| 2018 | $0.55 | -7.91% |
| 2017 | $0.59 | 24.55% |
| 2016 | $0.48 | 26.28% |
| 2015 | $0.38 | 27.12% |
| 2014 | $0.30 | 89.08% |
| 2013 | $0.16 | 35.47% |
| 2012 | $0.12 | 33.80% |
| 2011 | $0.09 | 50.52% |
| 2010 | $0.06 | 51.05% |
| 2009 | $0.04 | -8.43% |
| 2008 | $0.04 | 62.11% |
| 2007 | $0.03 | 21.33% |
| 2006 | $0.02 | 22.67% |
| 2005 | $0.02 | 0.00% |
EPS van vergelijkbare bedrijven of concurrenten
| Bedrijf | EPS | EPS-verschil | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -44.51% |
IN
|
